A detailed history of Met Life Investment Management, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 44,960 shares of HUMA stock, worth $88,121. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,960
Previous 52,295 14.03%
Holding current value
$88,121
Previous $284,000 20.07%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$3.46 - $5.81 $25,379 - $42,616
-7,335 Reduced 14.03%
44,960 $227,000
Q2 2024

Aug 13, 2024

BUY
$2.87 - $9.1 $52,523 - $166,539
18,301 Added 53.84%
52,295 $251,000
Q1 2024

May 14, 2024

BUY
$2.57 - $4.84 $87,364 - $164,530
33,994 New
33,994 $105,000
Q2 2023

Apr 29, 2024

BUY
$2.86 - $4.97 $99,894 - $173,592
34,928 New
34,928 $99,000
Q1 2023

May 09, 2024

BUY
$2.11 - $3.25 $73,698 - $113,516
34,928 New
34,928 $108 Million
Q4 2022

May 10, 2024

BUY
$2.02 - $3.62 $70,554 - $126,439
34,928 New
34,928 $73,000
Q4 2022

Feb 15, 2023

BUY
$2.02 - $3.62 $70,554 - $126,439
34,928 New
34,928 $73,000

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $202M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.